Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced, Resectable”

333 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 333 results

Large-scale testing (Phase 3)Looking for participantsNCT04138212
What this trial is testing

Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital 456
Testing effectiveness (Phase 2)Looking for participantsNCT06444009
What this trial is testing

A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Lei Liu 90
Early research (Phase 1)Looking for participantsNCT07300241
What this trial is testing

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell CarcinomaRCC+6 more
Neomorph, Inc 30
Testing effectiveness (Phase 2)Ended earlyNCT01688336
What this trial is testing

FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT00578071
What this trial is testing

Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer

Who this might be right for
Cancer of the Esophagus
Brian Czito 29
Not applicableLooking for participantsNCT04973293
What this trial is testing

Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer

Who this might be right for
Lung Neoplasm Malignant
Ruijin Hospital 20
Not applicableNot Yet RecruitingNCT07326189
What this trial is testing

Preoperative Right Hepatic Artery Embolization for Locally Advanced Bismuth IIIb and IV Perihilar Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectable
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04846634
What this trial is testing

Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)

Who this might be right for
Resectable Locally Advanced Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 90
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07386704
What this trial is testing

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Peking University First Hospital 30
Not applicableUnknownNCT03443921
What this trial is testing

Divestment for Artery-involved Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic CancerNeoadjuvant Therapy+1 more
The First Affiliated Hospital with Nanjing Medical University 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT04986930
What this trial is testing

MFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Cancer Non-resectable
Asan Medical Center 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06814067
What this trial is testing

Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma HNSCC
Fudan University 80
Testing effectiveness (Phase 2)UnknownNCT06235918
What this trial is testing

Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomasResectable Head and Neck Squamous-cell Carcinoma
Xiang Lu 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07463313
What this trial is testing

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

Who this might be right for
Thymoma and Thymic Carcinoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 116
Testing effectiveness (Phase 2)Looking for participantsNCT06663059
What this trial is testing

Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study

Who this might be right for
Esophageal Cancer
Tang-Du Hospital 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07147426
What this trial is testing

Tislelizumab Combined With Chemotherapy for Different Cycles of Neoadjuvant Therapy for Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck (NeoTempo)

Who this might be right for
Head &Amp; Neck Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 100
Large-scale testing (Phase 3)UnknownNCT01523015
What this trial is testing

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal Junction
Medical University of Lublin 100
Early research (Phase 1)Not Yet RecruitingNCT07488884
What this trial is testing

Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer ResectablePancreatic Cancer
ImmunityBio, Inc. 30
Not applicableLooking for participantsNCT06574620
What this trial is testing

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Who this might be right for
Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal Adenocarcinoma+1 more
British Columbia Cancer Agency 200
Testing effectiveness (Phase 2)Looking for participantsNCT06869213
What this trial is testing

A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma

Who this might be right for
Esophageal Cancer (EsC)
Peking University Cancer Hospital & Institute 30
Load More Results